Estuary Biotherapeutics, Inc., a biotechnology company developing genetic medicines for patients with serious kidney diseases, today announced its launch with $103 million in total committed financing ...
Artificial intelligence has sparked conversations and predictions. Technology leaders compare it to the Industrial Revolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results